|
FI75561C
(fi)
*
|
1979-10-30 |
1988-07-11 |
Ciba Geigy Ag |
Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
|
|
EP0108715A1
(de)
*
|
1982-10-15 |
1984-05-16 |
Ciba-Geigy Ag |
Dibenzazepincarboxamide
|
|
FR2700117B1
(fr)
*
|
1993-01-07 |
1995-02-03 |
Rhone Poulenc Rorer Sa |
Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
|
|
US5472714A
(en)
*
|
1993-09-08 |
1995-12-05 |
Ciba-Geigy Corporation |
Double-layered oxcarbazepine tablets
|
|
IT1272897B
(it)
*
|
1995-01-13 |
1997-07-01 |
I F C Iniziative Finanziaarie |
Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
|
|
PT101732B
(pt)
*
|
1995-06-30 |
1997-12-31 |
Portela & Ca Sa |
Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
|
|
PT101876B
(pt)
*
|
1996-05-27 |
1999-09-30 |
Portela & Ca Sa |
Novos derivados de 10,11-di-hidro-10-oxo-5h-dibenzo(b,f)azepina-5-carboxamida
|
|
US20020022056A1
(en)
*
|
1997-02-14 |
2002-02-21 |
Burkhard Schlutermann |
Oxacarbazepine film-coated tablets
|
|
AT406957B
(de)
*
|
1998-11-25 |
2000-11-27 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur oxidation von methyl-, methylen- oder methingruppen enthaltenden substraten
|
|
ATE224347T1
(de)
|
1998-11-25 |
2002-10-15 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur oxidation von methyl-, methylen- oder methingruppen enthaltenden substraten
|
|
GB9930058D0
(en)
|
1999-12-20 |
2000-02-09 |
Novartis Ag |
Organic compounds
|
|
IT1317854B1
(it)
*
|
2000-02-25 |
2003-07-15 |
Farchemia Srl |
5-ciano-10-idrossi-10,11-diidro-5h-dibenz(b,f)azepina e procedimentiper la sua preparazione e per la sua conversione in
|
|
CA2437402A1
(en)
*
|
2001-02-12 |
2002-08-22 |
Teva Pharmaceutical Industries, Ltd. |
New crystal forms of oxcarbazepine and processes for their preparation
|
|
TW200501962A
(en)
*
|
2003-04-01 |
2005-01-16 |
Novartis Ag |
Use of carbamazepine derivatives for the treatment of agitation in dementia patients
|
|
MXPA06002392A
(es)
|
2003-09-03 |
2006-06-20 |
Novartis Ag |
Uso de oxcarbazepina para el tratamiento de dolor neuropatico diabetico y la mejora del sueno.
|
|
EP1678140A2
(en)
*
|
2003-10-20 |
2006-07-12 |
Amoli Organics Ltd. |
Novel process for preparation of 10-oxo-10, 11-dihydro-5h-dibenz [b,f]azepine-5-carboxamide (oxcarbazepine) via intermediate, 10-methoxy-5h-dibenz [b,f] azepine-5-carbonylchloride
|
|
ITMI20040452A1
(it)
*
|
2004-03-09 |
2004-06-09 |
Clariant Lsm Italia Spa |
Processo per la preparazione di oxcarbazepina
|
|
US7459553B2
(en)
*
|
2004-03-11 |
2008-12-02 |
Glenmark Generics Ltd. |
Process for the preparation of carboxamide compounds
|
|
WO2005096709A2
(en)
*
|
2004-03-11 |
2005-10-20 |
Sun Pharmaceutical Industries Limited |
A process for the preparation of 10,11-dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
|
|
EP1600443A1
(en)
*
|
2004-05-26 |
2005-11-30 |
Alberto Milanese |
Process for the preparation of oxcarbazepine
|
|
CA2471666C
(en)
*
|
2004-06-18 |
2009-10-13 |
Apotex Pharmachem Inc. |
An improved process for the preparation of oxcarbazepine and related intermediates
|
|
US20060252745A1
(en)
*
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
|
EP2026815B1
(en)
|
2006-04-26 |
2011-01-26 |
Supernus Pharmaceuticals, Inc. |
Controlled released preparations of oxcarbazepine having sigmoidal release profile
|
|
GB0700773D0
(en)
|
2007-01-15 |
2007-02-21 |
Portela & Ca Sa |
Drug therapies
|
|
US20090082335A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched oxcarbazepine
|
|
AU2008331868B2
(en)
|
2007-11-28 |
2015-02-12 |
Nektar Therapeutics |
Oligomer-tricyclic conjugates
|
|
US8530647B2
(en)
*
|
2008-05-08 |
2013-09-10 |
Mylan Laboratories Limited |
Process for the preparation of oxcarbazepine
|
|
WO2011091050A1
(en)
|
2010-01-19 |
2011-07-28 |
Nektar Therapeutics |
Oligomer-tricyclic conjugates
|
|
US20150232426A1
(en)
|
2012-09-26 |
2015-08-20 |
Ranbaxy Laboratories Limited |
Process for the preparation of oxcarbazepine and its use as intermediate in the preparation of eslicarbazepine acetate
|
|
MX2018008021A
(es)
|
2015-12-30 |
2018-11-09 |
Adamas Pharmaceuticals Inc |
Metodos y composiciones para el tratamiento de trastornos relacionados con convulsiones.
|
|
MX388586B
(es)
|
2016-12-16 |
2025-03-20 |
Idorsia Pharmaceuticals Ltd |
Combinacion farmaceutica que comprende un bloqueador del canal de calcio de tipo t.
|
|
US10639313B2
(en)
|
2017-09-01 |
2020-05-05 |
Ndsu Research Foundation |
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
|
|
AU2019348194B2
(en)
|
2018-09-28 |
2025-04-03 |
Griffith University |
Agents and methods for modulating pathogen activity
|